Australia’s drug regulator has greenlit NeuroScientific to treat its first patients with Crohn’s disease using the company’s patented stem cell therapy, “StemSmart”.
Business / Companies
Brisbane Times – Business
Australia’s drug regulator has greenlit NeuroScientific to treat its first patients with Crohn’s disease using the company’s patented stem cell therapy, “StemSmart”.
Business / Companies
Brisbane Times – Business